Improving care for patients with respiratory tract infections

Journal of Chemotherapy

Volumn 14, Issue SUPPL. 2, 2002, Pages 22-28

  Lode, H ^a   Garau, J ^a  

^a Zentralklinik Emil von Behring   (Germany)

Author keywords

Clinical efficacy; Moxifloxacin; Patient satisfaction

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFUROXIME AXETIL; CLARITHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; ROXITHROMYCIN; TROVAFLOXACIN;

AMBULATORY CARE; CHRONIC BRONCHITIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DRUG COST; DRUG EFFICACY; HEALTH CARE QUALITY; HUMAN; META ANALYSIS; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT COMPLIANCE; PNEUMONIA; RESPIRATORY TRACT INFECTION; REVIEW; SINUSITIS; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BRONCHITIS; CHRONIC DISEASE; CLINICAL TRIALS; COMMUNITY-ACQUIRED INFECTIONS; FLUOROQUINOLONES; HUMANS; PATIENT SATISFACTION; PNEUMONIA; QUALITY OF HEALTH CARE; QUINOLINES; SINUSITIS;

EID: 0036218929     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Loss of work productivity due to illness and medical treatment
2. Low dosage and long treatment duration of beta-lactams: Risk factors for carriage of penicillin-resistant S. pneumoniae
3. Epidemiology of respiratory tract infection
4. Antimicrobial resistance of S. pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998-1999: Results of a national surveillance study
5. Expanded activity and utility of the new fluoroquinolones: A review
6. Concentration of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy
7. Treatment costs of acute exacerbations of chronic bronchitis
8. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbation of chronic bronchitis
9. Short course moxifloxacin therapy for treatment of acute exacerbations of chronic bronchitis
10. A multinational, multicentre, non-blinded randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis
11. The safety and efficacy of short-course moxifloxacin vs azithromycin in the treatment of patients with acute axacerbation of chronic bronchitis
12. A comparison of moxifloxacin and azithromycin in the treatment of acute exacerbations of chronic bronchitis
13. Safety and efficacy of moxifloxacin vs levofloxacin in the treatment of AECB
14. Short course (5 day) moxifloxacin versus 7-day levofloxacin therapy for treatment of acute exacerbations of chronic bronchitis
15. Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone moxifloxacin
16. Moxifloxacin in acute exacerbations of chronic bronchitis: Clinical evaluation and assessment by patients
17. Treatment outcomes in acute exacerbations of chronic bronchitis: Comparison of macrolides and moxifloxacin from the patient perspective
18. The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: A Spanish physician and patient perspective
19. Acute sinusitis in adults. Difficult to diagnose, essential to treat
20. Acute community-acquired sinusitis
21. Antimicrobial therapy for sinusitis
22. In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against S. pneumoniae, H. influenzae, and M. catarrhalis
23. Comparison of the in vitro activities of BAY 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes
24. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis
25. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis
26. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults
27. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience
28. Safety and efficacy of moxifloxacin versus amoxicillin clavulanate in the treatment of acute sinusitis
29. Moxifloxacin versus trovafloxacin in the treatment of acute sinusitis
30. The efficacy of moxifloxacin compared to levofloxacin and amoxicillin clavulanate in reducing "practice time use" for the treatmentof acute bacterial sinusitis
31. Treatment of pneumococcal pneumonia
32. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention
33. Efficacy and safety of 10-day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia
34. Efficacy and safety of moxifloxacin vs clarithromycin for community-acquired pneumonia
35. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia
36. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate community-acquired suspected pneumococcal pneumonia in adults
37. Efficacy, onset of action, and tolerability of moxifloxacin in patients with community-acquire pneumonia
38. Moxifloxacin IV/PO compared with amoxicillin/clavulanate IV/PO with or without clarithromycin in the treatment of community-acquired pneumonia
39. Efficacy and safety of sequential (IV/PO) moxifloxacin for the treatment of community-acquired pneumonia in hospitalised patients